Hypersensitivity to antihistamines

Allergy and Asthma Proceedings

Volumn 34, Issue 6, 2013, Pages 488-496

  Shakouri, Alireza A ^a   Bahna, Sami L ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; AZELASTINE; BEPOTASTINE; CETIRIZINE; CHLORPHENIRAMINE; CIMETIDINE; CLARITIN D; CYPROHEPTADINE; DESLORATADINE; DEXCHLORPHENIRAMINE; DIMENHYDRINATE; DIPHENHYDRAMINE; DOXEPIN; EBASTINE; FAMOTIDINE; FEXOFENADINE; FEXOFENADINE PLUS PSEUDOEPHEDRINE; HYDROXYZINE; HYDROXYZINE EMBONATE; LEVOCETIRIZINE; LORATADINE; MEBHYDROLIN; MEQUITAZINE; MIZOLASTINE; NIZATIDINE; OLOPATADINE; PHENIRAMINE; PHENIRAMINE MALEATE; PROMETHAZINE; PSEUDOEPHEDRINE; RANITIDINE; RUPATADINE; UNCLASSIFIED DRUG; ZYRTEC D;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADULT; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; BLOOD CELL COUNT; CASE REPORT; CONTACT DERMATITIS; COUGHING; CRAB MEAT; DERMATOPHAGOIDES; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ECZEMA; EOSINOPHILIA; FEMALE; FIXED DRUG ERUPTION; FOOD ALLERGY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LOBSTER; LUNG AUSCULTATION; NOSE POLYP; PHOTOALLERGY; PRURITUS; SHELLFISH; SHRIMP; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

ADULT; DRUG HYPERSENSITIVITY; EPINEPHRINE; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; HYDROXYZINE; PREDNISONE; PRURITUS; SKIN TESTS; SPIROMETRY; URTICARIA;

EID: 84888411923     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3699     Document Type: Article

References (83)

1. Epstein E. Dermatitis due to antihistaminic agents. J Invest Dermatol 12:151, 1949.
2. Stingeni L, Caraffini S, Agostinelli D, et al. Maculopapular and urticarial eruption from cetirizine. Contact Dermatitis 37:249-250, 1997.
3. Karamfilov T, Wilmer A, Hipler UC, and Wollina U. Cetirizineinduced urticarial reaction. Br J Dermatol 140:979-980, 1999.
4. Demoly P, Messaad D, Benahmed S, et al. Hypersensitivity to H1-antihistamines. Allergy 55:679-680, 2000.
5. Calista D, Schianchi S, and Morri M. Urticaria induced by cetirizine. Br J Dermatol 144:196, 2001.
6. Tella R, Gaig P, Bartra J, and Garcia-Ortega P. Urticaria to cetirizine. J Investig Allergol Clin Immunol 12:136-137, 2002.
7. SchröterS, Damveld B, and Marsch WC. Urticarial intolerance reaction to cetirizine. Clin Exp Dermatol 27:185-187, 2002.
8. Kränke B, and Mayr-Kanhäuser S. Urticarial reaction to the antihistamine levocetirizine dihydrochloride. Dermatology 210:246-247, 2005.
9. Gonzalez de Olano D, Roan Roan J, de la Hoz Caballer B, et al. Urticaria induced by antihistamines. J Investig Allergol Clin Immunol 16:144-146, 2006.
10. Inomata N, Tatewaki S, and Ikezawa Z. Multiple H1-antihista-mine-induced urticaria. J Dermatol 36:224-227, 2009.
11. Rodriguez del Rio P, Gonzalez-Gutierrez ML, Sanchez-Lopez J, et al. Urticaria caused by antihistamines: Report of 5 cases. J Investig Allergol Clin Immunol 19:317-320, 2009.
12. Sanchez Morillas L, Rojas Perez-Ezquerra P, Reano Martos M, et al. Urticaria due to antihistamines. J Investig Allergol Clin Immunol 21:66-68, 2011.
13. Lee SW, Byun JY, Choi YW, et al. Fexofenadine-induced urticaria. Ann Dermatol 23(suppl 3):S329-S332, 2011.
14. Devalia JL, De Vos C, Hanotte F, and Baltes E. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 56:50-57, 2001.
15. Picardo M, and Santucci B. Urticaria from ranitidine. Contact Dermatitis 9:327, 1983.
16. Hogan DJ, and Rooney ME. Fixed drug eruption due to dimenhydrinate. J Am Acad Dermatol 20:503-504, 1989.
17. Dwyer CM, and Dick D. Fixed drug eruption caused by diphenhydramine. J Am Acad Dermatol 29:496-497, 1993.
18. Gonzalo-Garijo MA, Revenga-Arranz F. Fixed drug eruption due to dimenhydrinate. Br J Dermatol. 135(4):661-662, 1996.
19. Smola H, Kruppa A, Hunzelmann N, et al. Identification of dimenhydrinate as the causative agent in fixed drug eruption using patch-testing in previously affected skin. Br J Dermatol 138:920-921, 1998.
20. Kranke B, and Kern T. Multilocalized fixed drug eruption to the antihistamine cetirizine. J Allergy Clin Immunol 106:988, 2000.
21. Saenz de San Pedro B, Quiralte J, and Florido JF. Fixed drug eruption caused by dimenhydrinate. Allergy 55:297, 2000.
22. Gharami RC. An unusual reaction to a commonly used drug. Indian J Dermatol Venereol Leprol 67:107, 2001.
23. Assouere MN, Mazereeuw-Hautier J, and Bonafe JL. Cutaneous drug eruption with two antihistaminic drugs of a same chemical family: Cetirizine and hydroxyzine. Ann Dermatol Venereol 129:1295-1298, 2002.
24. Inamadar AC, Palit A, Athanikar SB, et al. Multiple fixed drug eruptions due to cetirizine. Br J Dermatol 147:1025-1026, 2002.
25. Mahajan VK, Sharma NL, and Sharma VC. Fixed drug eruption: A novel side-effect of levocetirizine. Int J Dermatol 44:796-798, 2005.
26. Cravo M, Goncalo M, and Figueiredo A. Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives. Int J Dermatol 46:760-762, 2007.
27. Rodriguez-Jimenez B, Dominguez-Ortega J, Gonzalez-Garcia JM, and Kindelan-Recarte C. Dimenhydrinate-induced fixed drug eruption in a patient who tolerated other antihistamines. J Investig Allergol Clin Immunol 19:334-335, 2009.
28. Giatrakou S, Papadavid E, Kalogeromitros D, et al. Fixed drug eruption caused by dimenhydrinate. J Am Acad Dermatol 64:608-610, 2011.
29. Guptha SD, Prabhakar SM, and Sacchidanand S. Fixed drug eruption due to levocetirizine. Indian J Dermatol Venereol Leprol 71:361-362, 2005.
30. Ruiz-Genao DP, Hernandez-Nunez A, Sanchez-Perez J, and Garcia-Diez A. Fixed drug eruption due to loratadine. Br J Dermatol 146:528-529, 2002.
31. Pionetti CH, Kien MC, and Alonso A. Fixed drug eruption due to loratadine. Allergol Immunopathol (Madr) 31:291-293, 2003.
32. Bonnel RA, La Grenade L, Karwoski CB, and Beitz JG. Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. J Am Acad Dermatol 48:294-296, 2003.
33. Taylor JS, Praditsuwan P, Handel D, and Kuffner G. Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience. Arch Dermatol 132:515-518, 1996.
34. Brancaccio RR, and Weinstein S. Systemic contact dermatitis to doxepin. J Drugs Dermatol 2:409-410, 2003.
35. Goh CL, and Ng SK. Allergic contact dermatitis to ranitidine. Contact Dermatitis 11:252, 1984.
36. Alomar A, Puig L, and Vilaltella I. Allergic contact dermatitis due to ranitidine. Contact Dermatitis 17:54-55, 1987.
37. Romaguera C, Grimalt F, and Vilaplana J. Epidemic of occupational contact dermatitis from ranitidine. Contact Dermatitis 18:177-178, 1988.
38. Ryan PJ, Rycroft RJ, and Aston IR. Allergic contact dermatitis from occupational exposure to ranitidine hydrochloride. Contact Dermatitis 48:67- 68, 2003.
39. Tosti A, Bardazzi F, and Piancastelli E. Contact dermatitis due to chlorpheniramine maleate in eyedrops. Contact Dermatitis 22:55, 1990.
40. Parente G, Pazzaglia M, Vincenzi C, and Tosti A. Contact dermatitis from pheniramine maleate in eyedrops. Contact Dermatitis 40:338, 1999.
41. Suchi ST, Gupta A, and Srinivasan R. Contact allergic dermatitis and periocular depigmentation after using olopatadine eye drops. Indian J Ophthalmol 56:439-440, 2008.
42. Schreiber MM, and Naylor LZ. Antihistamine photosensitivity. Arch Dermatol 86:58-62, 1962.
43. Horio T. Allergic and photoallergic dermatitis from diphenhydramine. Arch Dermatol 112:1124-1126, 1976.
44. Emmett EA. Diphenhydramine photoallergy. Arch Dermatol 110:249-252, 1974.
45. Yamada S, Tanaka M, Kawahara Y, et al. Photoallergic contact dermatitis due to diphenhydramine hydrochloride. Contact Dermatitis 38:282, 1998.
46. Kondo S, Kagaya M, Yamada Y, et al. UVB photosensitivity due to ranitidine. Dermatology 201:71-73, 2000.
47. Todd P, Norris P, Hawk JL, and Du Vivier AW. Ranitidineinduced photosensitivity. Clin Exp Dermatol 20:146-148, 1995.
48. Rietschel RL, Fowler JF, and Fisher AA. Antihistamine dermatitis. Fisher's Contact Dermatitis, 5th ed., Rietschel RL and Fowler JF Jr (Eds). Philadelphia, PA: Lippincott Williams & Wilkins, 185-192, 2001.
49. Michel M, Dompmartin A, Louvet S, et al. Skin reactions to hydroxyzine. Contact Dermatitis 36:147-149, 1997.
50. Ash S, and Scheman AJ. Systemic contact dermatitis to hydroxyzine. Am J Contact Dermat 8:2-5, 1997.
51. Lew BL, Haw CR, and Lee MH. Cutaneous drug eruption from cetirizine and hydroxyzine. J Am Acad Dermatol 50:953-956, 2004.
52. Reid N, Jariwala S, Hudes G, et al. Worsening of contact dermatitis by oral hydroxyzine: A case report. Dermatol Online J 19:4, 2013.
53. Cusano F, Ferrara G, Crisman G, et al. Clinicopathologic features of systemic contact dermatitis from ethylenediamine in cetirizine and levocetirizine. Dermatology 213:353-355, 2006.
54. Miralles ES, Nunez M, del Olmo N, and Ledo A. Ranitidinerelated toxic epidermal necrolysis in a patient with idiopathic thrombocytopenic purpura. J Am Acad Dermatol 32:133-134, 1995.
55. Velez A, and Moreno JC. Second case of ranitidine-related toxic epidermal necrolysis in a patient with idiopathic thrombocytopenic purpura. J Am Acad Dermatol 42:305, 2000.
56. Blanes Martinez M, Silvestre Salvador JF, Vergara Aguilera G, et al. Acute generalized exanthematous pustulosis induced by ranitidine hydrochloride. Contact Dermatitis 49:47, 2003.
57. Vythoulka A, Pitsios C, and Kompoti E. Allergic reactions due to mizolastine. Ann Allergy Asthma Immunol 97:262-263, 2006.
58. Gonzalo-Garijo MA, Jimenez-Ferrera G, Bobadilla-Gonzalez P, and Cordobes-Duran C. Hypersensitivity reaction to mizolastine: Study of cross reactions. J Investig Allergol Clin Immunol 16:391-393, 2006.
59. Barranco P, Lopez-Serrano MC, and Moreno-Ancillo A. Anaphylactic reaction due to diphenhydramine. Allergy 53:814, 1998.
60. Mur Gimeno P, Alfaya Arias T, Iglesias Aranzazu M, et al. Anaphylactic shock caused by antihistamines. J Investig Allergol Clin Immunol 21:321-322, 2011.
61. Weidinger S, Mempel M, Ollert M, et al. Anaphylaxis to mizolastine. J Allergy Clin Immunol 114:979-981, 2004.
62. Thurot-Guillou C, Bourrain JL, Jacquier JP, and Beani JC. Anaphylactic reaction to ranitidine and dexchlorpheniramine. Eur J Dermatol 17:170-171, 2007.
63. Greer IA, and Fellows K. Anaphylactoid reaction to ranitidine in labour. Br J Clin Pract 44:78, 1990.
64. Barry JE, Madan R, and Hewitt PB. Anaphylactoid reaction to ranitidine in an obstetric patient. Anaesthesia 47:360-361, 1992.
65. Lazaro M, Compaired JA, De La Hoz B, et al. Anaphylactic reaction to ranitidine. Allergy 48:385-387, 1993.
66. Powell JA, and Maycock EJ. Anaphylactoid reaction to ranitidine in an obstetric patient. Anaesth Intensive Care 21:702-703, 1993.
67. Kaneko K, and Maruta H. Severe anaphylactoid reaction to ranitidine in a parturient with subsequent fetal distress. J Anesth 17:199-200, 2003.
68. Koh YI, Park HS, and Choi IS. Ranitidine-induced anaphylaxis: Detection of serum specific IgE antibody. Allergy 61:269-270, 2006.
69. Demirkan K, Bozkurt B, Karakaya G, and Kalyoncu AF. Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 Case reports and review of the literature. J Investig Allergol Clin Immunol 16:203-209, 2006.
70. Rethnam U, and Yesupalan RS. Anaphylactic reaction associated with Ranitidine in a patient with acute pancreatitis: A case report. J Med Case Rep 1:75, 2007.
71. Oliva A, Partemi S, Arena V, et al. Fatal injection of ranitidine: A case report. J Med Case Rep 2:232, 2008.
72. Foti C, Cassano N, Panebianco R, et al. Hypersensitivity reaction to ranitidine: Description of a case and review of the literature. Immunopharmacol Immunotoxicol 31:414-416, 2009.
73. Castro AL, Carmona JB, Gonzalez FG, et al. Anaphylaxis due to treatment of gastric protection. Ann Allergy Asthma Immunol 102:532, 2009.
74. Walker AI, Werfel S, Kick G, and Przybilla B. Repeated anaphylactic responses induced by oral challenge with ranitidine. Acta Derm Venereol 90:189, 2010.
75. Han TY, Jang WS, Yu M, et al. Anaphylactic reaction to ranitidine (Zantac(R)). Int J Dermatol 50:1397-1399, 2011.
76. Song WJ, Kim MH, Lee SM, et al. Two cases of h(2)-receptor antagonist hypersensitivity and cross-reactivity. Allergy Asthma Immunol Res 3:128-131, 2011.
77. Aouam K, Bouida W, Ben Fredj N, et al. Severe ranitidineinduced anaphylaxis: A case report and literature review. J Clin Pharm Ther 37:494-496, 2012.
78. Antonicelli L, Stagnozzi G, Massaccesi C, et al. Intraoperative anaphylaxis: A case report of allergy to ranitidine. Eur Ann Allergy Clin Immunol 44:253-255, 2012.
79. Kim YI, Park CK, Park DJ, et al. A case of famotidine-induced anaphylaxis. J Investig Allergol Clin Immunol 20:166-169, 2010.
80. Mira-Perceval JL, Ortiz JL, Sarrio F, et al. Nizatidine anaphylaxis. J Allergy Clin Immunol 97:855- 856, 1996.
81. Kulthanan K, Tiprungkorn P, and Linpiyawan R. Cutaneous reaction to oral antihistamine. Clin Exp Dermatol 28:229-230, 2003.
82. Yilmaz-Demirdag Y, Mahmoud SA, and Bahna SL. Antihistamines drugs. In Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice, 4th ed., Chap. 39. Yaffe SJ, and Aranda JV (Eds). Philadelphia PA: Lippincott, Williams & Wilkins, 558-573, 2010.
83. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: General considerations. Allergy 58:854-863, 2003.